HPV Vaccination for Men: Age, Doses and Expected Protection

HPV vaccination can protect males against future infections with vaccine-covered human papillomavirus types and thereby reduce the risk of diseases those types can cause, including genital warts and several HPV-related cancers. Its preventive benefit is greatest before exposure to HPV, but previous sexual activity or a history of genital warts does not automatically remove all potential benefit. The vaccine does not treat an existing HPV infection or wart. Age eligibility and dose schedules differ between countries, public-health programmes and authorised products, so there is no single worldwide schedule for every adult man.

What can HPV vaccination prevent in men?

Depending on the vaccine and local authorisation, HPV vaccination can reduce the risk of new infection with HPV types associated with:

• genital warts;
• anal precancer and cancer;
• other HPV-related cancers, including a proportion of penile and oropharyngeal cancers.

The European Medicines Agency states that the 9-valent HPV vaccine is authorised in males and females from age nine for prevention of genital warts and specified HPV-related premalignant lesions and cancers, with use according to official recommendations.

Vaccination is prevention. It is not a treatment for an abnormal lesion that already exists.

Does the HPV vaccine treat existing HPV or genital warts?

No. HPV vaccines are prophylactic vaccines. They prevent new infections with covered HPV types but do not eradicate an existing HPV infection and do not make a current genital wart disappear.

This distinction remains important after a person has already had HPV:

• vaccination does not replace examination of a visible lesion;
• vaccination does not replace treatment of a wart when treatment is appropriate;
• vaccination does not reverse existing HPV-related precancer;
• vaccination does not prove that a previous HPV infection has cleared.

A history of HPV does not necessarily mean the person has encountered every HPV type included in the vaccine.

At what age is HPV vaccination recommended for males?

The answer depends on the country.

United States CDC recommendations

CDC recommends routine HPV vaccination at ages 11–12, with vaccination able to start at age 9. Catch-up vaccination is recommended through age 26 for people who were not adequately vaccinated when younger.

For some adults aged 27–45 who were not adequately vaccinated, CDC recommends shared clinical decision-making rather than routine vaccination for everyone in that age group. Average benefit is lower because prior HPV exposure becomes more likely with age, but benefit may still exist for selected adults.

European authorisation

EMA authorises Gardasil 9 for males and females from age 9, while stating that use should follow official recommendations. Authorisation and a country’s routine public-health recommendation are not the same thing.

WHO programme recommendations

WHO’s population-level HPV programme recommendations primarily prioritise vaccination of girls before sexual exposure because cervical-cancer prevention is the central global public-health target. WHO also supports vaccination of secondary target groups such as boys where feasible and affordable. Many national programmes have adopted different schedules, including single-dose strategies in selected age groups.

For an international patient page, these systems should not be collapsed into one “global rule”.

Can HPV vaccination still be useful after age 26?

For some adults, yes, but the expected benefit is more individual.

CDC’s shared decision-making framework for ages 27–45 considers that:

• many sexually active adults have already encountered HPV, but not necessarily every vaccine-covered type;
• a new sexual partner at any age can create a new opportunity for HPV exposure;
• people in long-term mutually monogamous relationships are less likely to acquire a new HPV infection;
• the vaccine prevents future infection rather than treating past infection.

Age does not make the vaccine suddenly biologically ineffective on a birthday. The issue is that the average preventable benefit changes with prior exposure and future risk.

How many HPV vaccine doses do men need?

Dose schedules must be checked against the applicable national programme and authorised product information.

CDC schedule as an example

Under current CDC recommendations:

• most people who start the series before their 15th birthday receive a two-dose series;
• people who start at age 15 or later and are within the routine/catch-up programme receive a three-dose series;
• immunocompromised people, including those with HIV, receive a three-dose series in the relevant age range.

The timing between doses is also defined by CDC, but this page does not provide a personalised injection schedule.

EMA product information

EMA product information for Gardasil 9 also uses age-dependent two- or three-dose schedules and states that the vaccine should be administered according to official recommendations.

WHO programmes may differ

WHO supports reduced-dose approaches, including one-dose schedules for certain public-health target groups. These WHO programme recommendations are not identical to CDC or EMA product schedules.

The correct schedule for an individual therefore depends on country, age at first dose, immune status, vaccine product and previous valid doses.

If a dose is late, does the series need to be restarted?

Usually not. CDC immunisation guidance indicates that an interrupted HPV series generally does not need to be restarted; the remaining dose or doses are completed using valid minimum intervals.

The previous record matters. Before deciding what is missing, it helps to confirm:

• age at the first dose;
• number of doses received;
• dates of those doses;
• which vaccine product was used, if known;
• whether the person is immunocompromised.

When records are incomplete or vaccinations occurred in different countries, the completion plan should be checked against the current national schedule.

Is an HPV test required before vaccination?

No. CDC does not recommend HPV testing, cervical testing or antibody testing simply to decide whether HPV vaccination is appropriate.

For men, this is particularly important because there is no approved general screening test that determines a man’s overall HPV status.

A visible wart or other lesion should still be assessed, but that is a separate clinical question from whether vaccination is appropriate.

Can a man with genital warts still receive HPV vaccination?

A history of genital warts or HPV is not, by itself, a reason to assume that vaccination has no value. The person may not have been exposed to all vaccine-covered HPV types.

However:

• the vaccine will not treat the existing wart;
• it will not shorten a current wart-treatment course;
• it cannot be promised to prevent recurrence of a wart that has already developed;
• age and local vaccination recommendations still apply.

The wart and the vaccination decision should therefore be managed as related but distinct issues.

Can HPV vaccination be given after sexual activity has started?

Yes, when the person is eligible under the relevant recommendations. Previous sexual activity means HPV exposure may already have occurred, but it does not imply exposure to every vaccine-covered type.

The expected benefit is generally greatest before exposure. After sexual debut, the decision depends increasingly on age, vaccination history and likelihood of future new exposure.

What side effects can occur?

The most common adverse effects are generally short-lived and include:

• pain, redness or swelling at the injection site;
• headache;
• dizziness;
• nausea;
• fatigue or malaise;
• muscle aches.

Fainting can occur after injections, particularly in adolescents, so post-vaccination observation is commonly recommended to reduce injury from a fall.

Severe allergic reactions are rare but can occur after any vaccine and require urgent medical care.

Does HPV vaccination cause infertility or sexual dysfunction?

Current vaccine-safety monitoring does not support a causal link between HPV vaccination and infertility. CDC specifically states that HPV vaccination does not cause fertility problems.

There is likewise no established evidence that HPV vaccination causes erectile dysfunction or loss of sexual function. A symptom that begins after vaccination should still be clinically assessed on its own merits rather than automatically attributed to the vaccine.

Who should not receive the vaccine or should delay it?

Contraindications and precautions depend on the vaccine product and national guidance. CDC identifies a severe allergic reaction to a previous dose or vaccine component as a contraindication. Gardasil 9 is produced using yeast, so immediate hypersensitivity to yeast is relevant to that product.

Moderate or severe acute illness is generally a reason to defer vaccination until recovery. Minor illness is usually not a reason to postpone vaccination.

Product information should be checked for the specific vaccine being used.

Does vaccination make condoms unnecessary?

No. HPV vaccination does not protect against every HPV type and does not protect against other sexually transmitted infections.

Condoms and other barriers can reduce HPV transmission risk but do not eliminate it because uncovered genital skin may carry HPV. Vaccination and barrier use therefore address different parts of prevention.

Where can a man ask about HPV vaccination?

Depending on the country, eligibility and schedule can be reviewed through:

• primary care or family medicine;
• vaccination clinics;
• sexual-health services;
• infectious-disease services;
• other authorised vaccination providers.

A genital wart or uncertain penile lesion may also require separate urological or dermatological assessment. See which clinician may assess genital warts.

Common questions

Is HPV vaccination only for women?

No. HPV vaccines are authorised and recommended for males in many countries, although programme ages and funding differ.

Does a previous genital wart mean vaccination is pointless?

No. A previous wart does not prove exposure to every vaccine-covered HPV type. Eligibility still depends on age, previous vaccination and local recommendations.

Does vaccination clear a positive HPV test?

No. The vaccine prevents new vaccine-type infections; it does not treat an infection that is already present.

Is there one worldwide dosing schedule?

No. CDC, EMA product information, WHO programme recommendations and national immunisation schedules are not identical.

Can an adult over 45 receive the vaccine?

This depends on local authorisation and policy. In the United States, HPV vaccines are not licensed for adults older than 45. Other countries should be checked individually rather than extrapolating the U.S. rule globally.

Medical information note

HPV vaccination recommendations change by country, age, immune status and vaccine product. The dose examples on this page explain major current frameworks but should not be used as a personalised vaccination order. The applicable national immunisation guidance and authorised product information should be checked before vaccination.